Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Improving Inhaler Technique through Community Pharmacy Service Greater Manchester Area Team Autumn 2014 www.england.nhs.uk Service Specification www.england.nhs.uk Service Details • Built upon the MUR/Prescription Intervention advance service • Any patient eligible for a Prescription Intervention can be invited to join the scheme • Patients newly prescribed an inhaler should receive inhaler technique training via NMS- outside of this project • Patients entitled to one PI; one brief intervention; and one MUR in a 12 month period www.england.nhs.uk Inhaler Technique Patient Pathway Flow Chart 1 Step One Patient on inhaled medication and meets the standard requirements for a MUR. Step Two Patient asked the complete the ACT/CAT assessment. Is the score ≥ 20 for ACT or ≤ 10 for CAT? Yes Patient demonstrating good control, but may have poor technique. See flow chart 2 No Step Three Patient invited to participate in inhaler training Patient not had full MUR in last 12 months Prescription Intervention undertaken on inhaled medications only- claim via FP34c 6-8 weeks later Brief intervention follow up checkclaim via PharmOutcomes Full MUR within 12 months- claim via FP34c www.england.nhs.uk Patient had full MUR in last 12 months Prescription Intervention undertaken on inhaled medications only- claim via FP34c 6-8 weeks later Brief intervention follow up checkclaim via PharmOutcomes Inhaler Technique Patient Pathway Flow Chart 2 Patient has an ACT/CAT score ≥ 20 for ACT or ≤ 10 for CAT? Inspiration rate checked using InCheck® device In-correct inspiration rate demonstrated Correct inspiration rate demonstrated Does the patient meet the standard requirements for an MUR? Follow Flow Chart 1 from Step Three Yes Perform MUR- claim via FP34c www.england.nhs.uk No Patient to be invited back for an MUR when meets national eligibility criteria Service Details • Required data and patient consent to be captured on consultation form(s) • Information to be entered on to PharmOutcomes • Consultation form(s) to be retained in the pharmacy; copy to be sent to patients GP • Payment for PI to be claimed via FP34c (£28) • Payment for brief intervention generated via PharmOutcomes (£10) • Expressions of Interest to provide the scheme to be circulated to contractors shortly www.england.nhs.uk Premises Requirements • • • • PREM1 to be submitted to AT (if not previously done) Intervention to take place in the consultation room Telephone interventions are not allowed Offsite consultations are permitted, apply to the AT via the standard NHS England procedure http://www.england.nhs.uk/pharm-adv-serv/ • Signed SLA submitted to AT www.england.nhs.uk Pharmacist Accreditation www.england.nhs.uk Pharmacist requirements • Accredited to undertake MURs • Undergone face to face inhaler technique training since 2011 • Completed the Declaration of Competence for Improving Inhaler Technique through Community Pharmacy www.england.nhs.uk Declaration of Competence • Soon to be launched • Pharmacists that have undergone face to face inhaler technique training are able to start and accredit retrospectively • Contractors to be informed when DoC available, pharmacists providing the service will have 2 months after launch to complete • Copy of DoC to be kept in the pharmacy www.england.nhs.uk Top Tips www.england.nhs.uk Top Tips for Respiratory MURs 1. Check the patient’s PMR for frequency of ordering of medication before starting the review. For patients with asthma • Ordering more than twelve short-acting reliever inhalers over the last year may indicate poor control and that preventative treatments need to be stepped up. • Generally patients with asthma should require thirteen inhaled corticosteroid (ICS) preventer inhalers per year (might be less for 200 dose metered dose inhalers). • Is the patient prescribed a long-acting beta 2 agonist (LABA) without an ICS? This requires a review of the regimen. www.england.nhs.uk Top Tips for Respiratory MURs 2. What does the patient know about their condition and its treatment? 3. Has the patient had a review before? Who did the review? Does the patient see anyone else for their condition? Explain that the reviews are being done with the knowledge of GP practices in the area and that the aim is to improve medicines use for respiratory conditions. 4. Check adherence with the information from the PMR and document any reasons for non-adherence e.g. difficulty in using device, side-effects, perception of ineffectiveness, lack of knowledge of indications for different inhalers. Does the patient experience any problems taking / using their medicines? www.england.nhs.uk Top Tips for Respiratory MURs 5. Assess inhaler technique - use In-check device. Would the patient benefit from a device switch, adding a spacer? Does the patient have the same devices i.e. MDI or Turbohaler? 6. Does the patient know how to take other medicines prescribed for their respiratory condition e.g. rescue packs of corticosteroids / antibiotics, mucolytics or theophylline for COPD. 7. Give smoking cessation advice if appropriate. 8. Does the patient need flu or Pneumococcal vaccination? www.england.nhs.uk Top Tips for Respiratory MURs 9. Does the patient have any questions / need more information about their medicines? 10. Refer patients if they report: • An increase in exacerbations • Their symptoms are not controlled • Side-effects of medicines • Severe or life-threatening asthma exacerbation • Haemoptysis- spitting or coughing up blood www.england.nhs.uk Questions? agm.optometrypharmacy@nhs.net www.england.nhs.uk